ABCLONAL TECHNOLOGY
Live / Registered — Registered and renewed (as of 30 Jan 2026)
What this means for you
Registered since 30 Aug 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Aug 2026).
Record
- Serial number
- 86837812
- Registration number
- 5030497
- Mark type
- Design + words
- Filed
- 03 Dec 2015
- Published for opposition
- 14 Jun 2016
- Registered
- 30 Aug 2016
- Next maintenance due
- 30 Aug 2026
- Attorney of record
- Kevin L. Russell
Goods and services
- Class 001 — Chemicals: Biochemicals, namely, polyclonal antibodies for in vitro scientific or research use; diagnostic kits consisting of polyclonal antibodies, buffers, and reagents for scientific and research use; biochemicals, namely, polyclonal antibodies for the detection of antigens; diagnostic kits consisting of polyclonal antibodies, buffers, reagents for use in disease testing; biochemicals, namely, custom polyclonal antibodies specifically recognizing antigens provided by customer; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic kits consisting of monoclonal antibodies, buffers, and reagents for scientific and research use; biochemicals, namely, monoclonal antibodies for the detection of antigens; biochemicals, namely, custom monoclonal antibodies specifically recognizing antigens provided by customer; Enzyme-linked immunosorbent assay kits comprised of assays and reagents for scientific and research use; chemical reagents, namely, recombinant protein for scientific and research use; chemicals, namely, custom recombinant proteins manufactured for others; biochemical kits consisting of recombinant proteins, buffers, reagents for scientific and research use
- Class 005 — Pharmaceuticals: Diagnostic kits consisting of monoclonal antibodies, buffers, reagents for use in disease testing; Diagnostic kits consisting of recombinant proteins, buffers, reagents for use in disease testing
- Class 042 — Scientific and technological services: custom design and development of polyclonal antibodies specifically recognizing an antigen; custom design and development of kits consisting polyclonal antibodies specifically recognizing an antigen, buffers, reagents for scientific and research use; custom design and development of kits consisting of polyclonal antibodies specifically recognizing an antigen, buffers, reagents for detection of the antigen; custom design and development of monoclonal antibodies specifically recognizing an antigen; custom design and development of kits consisting of monoclonal antibodies specifically recognizing an antigen, buffers, reagents for scientific and research use; custom design and development of kits consisting of monoclonal antibodies specifically recognizing an antigen, buffers, reagents for detection of the antigen; custom design and development of recombinant proteins for others; Custom design and development of enzyme-linked immunosorbent assay kits consisting of polyclonal antibodies recognizing an antigen, buffers, reagents; Custom design and development of enzyme-linked immunosorbent assay kits consisting of monoclonal antibodies recognizing an antigen, buffers, reagents; Custom design and development of recombinant proteins for scientific and research use; Custom design and development of kits consisting of recombinant proteins, buffers, reagents for scientific and research use; Custom design and development of diagnostic kits consisting of recombinant proteins, buffers, reagents for use in disease testing
Owner
- Wuhan ABclonal Biotechnology Co., Ltd, Wuhan, CN
- Wuhan ABclonal Biotechnology Co., Ltd, Wuhan, CN
- Wuhan ABclonal Biotechnology Co., Ltd, Wuhan, CN
Prosecution history
- 30 Jan 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 30 Jan 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 30 Jan 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Oct 2025 — TEAS SECTION 8 & 9 RECEIVED
- 30 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Jan 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Jan 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Dec 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Sept 2021 — TEAS SECTION 8 & 15 RECEIVED
- 30 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 14 Jun 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jun 2016 — PUBLISHED FOR OPPOSITION
- 25 May 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED